Methohexital sodium

Sodium methohexital is a white powder. Methohexital sodium is the sodium salt of methohexital. Among its listed roles, it functions as a intravenous anaesthetic. It includes a methohexital(1-). Methohexital Sodium is the sodium salt of methohexital, a rapid, short-acting barbituric acid derivative, with anesthetic activity. Methohexital binds to the chloride ionophore site of the gamma-aminobutyric acid (GABA)-A/chloride ionophore receptor complex, thereby enhancing the inhibitory actions of GABA-A in the brain. This leads to synaptic inhibition, decreased neuronal excitability and induction of anesthesia. Additionally, this agent decreases glutamate (Glu) responses. Methohexital is only found in individuals that have used or taken this drug. It is an intravenous anesthetic with a short duration of action that may be used for induction of anesthesia. Methohexital binds at a distinct binding site associated with a Cl- ionopore at the GABAA receptor, increasing the duration of time for which the Cl- ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged. It is grouped under the following drug class(es): Barbiturates. Its therapeutic use is listed as anesthetics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Brevital, Brietal sodium and Sodium methohexital. Its PubChem CID is 23690443.

CAS No 309-36-4
Molecular Formula C14H17N2NaO3
Molecular Weight 284.29 g/mol
Synonyms sodium 5-hex-3-yn-2-yl-1-methyl-4,6-dioxo-5-prop-2-enylpyrimidin-2-olate

Frequently Asked Questions